Noronha Irene L, Ramalho Rodrigo José, Oliveira Claudia Maria Costa de, Bahiense-Oliveira Marilia, Barbosa Fabricio Augusto Marques, Barros Neto Jose de Resende, Mitsuoka Ronny, Vieira-Neto Osvaldo Merege, Neves Precil Diego Miranda de Menezes
Clinical Nephrology Department of the Brazilian Society of Nephrology, São Paulo, Brazil.
Renal Division, Hospital das Clínicas, University of São Paulo Medical School, São Paulo, Brazil.
PLoS One. 2025 Feb 10;20(2):e0312410. doi: 10.1371/journal.pone.0312410. eCollection 2025.
Kidney biopsy registries are valuable tools for guiding clinical practice and developing health policies. In 2021, the Brazilian Society of Nephrology (SBN) created the Brazilian Kidney Biopsy Registry (BKBR). This is the first BKBR report, presenting patient data from 2021.
BKBR is a web-based platform hosted on the BSN website, which contains patient demographics, clinical data, frequency, and distribution of histologic diagnosis of Brazilian adult native kidney biopsies.
Of the 1012 cases registered in 2021, 954 cases were evaluated after excluding pediatric and kidney transplant cases. Twenty-one centers enrolled patients, with representation from all Brazilian regions. There was a slight predominance of females (52.6%), a mean age of 44.7 ± 16 years, and 13.6% of patients were >65 years old. The main indication for kidney biopsy was renal dysfunction (56%) and nephrotic syndrome (41.4%), respectively. At the time of the biopsy, 47.9% of the patients were hypertensive and 15.2% were diabetic. Although 66.2% of patients had eGFR ≤60ml/min/1.73m2 upon biopsy, the majority (60.2%) had mild interstitial fibrosis and tubular atrophy. The most frequent diagnosis in the BKBR was glomerular disease (74.8%). Lupus nephritis was the most frequent diagnosis of glomerular disease (22.6%), followed by IgA nephropathy (13%) and focal segmental glomerulosclerosis (12.2%).
This is the first report of a Nationwide registry of kidney biopsies in Brazil. This data provides pivotal information about the kidney disease profile in this country with continental dimensions.
肾脏活检登记处是指导临床实践和制定卫生政策的宝贵工具。2021年,巴西肾脏病学会(SBN)创建了巴西肾脏活检登记处(BKBR)。这是首份BKBR报告,呈现了2021年的患者数据。
BKBR是一个基于网络的平台,托管在BSN网站上,包含巴西成年原发性肾脏活检患者的人口统计学、临床数据、频率以及组织学诊断分布。
2021年登记的1012例病例中,排除儿科和肾移植病例后,对954例进行了评估。21个中心纳入了患者,来自巴西所有地区。女性略占多数(52.6%),平均年龄为44.7±16岁,13.6%的患者年龄>65岁。肾脏活检的主要指征分别是肾功能不全(56%)和肾病综合征(41.4%)。活检时,47.9%的患者患有高血压,15.2%的患者患有糖尿病。尽管66.2%的患者活检时估算肾小球滤过率(eGFR)≤60ml/min/1.73m²,但大多数(60.2%)患者有轻度间质纤维化和肾小管萎缩。BKBR中最常见的诊断是肾小球疾病(74.8%)。狼疮性肾炎是肾小球疾病最常见的诊断(22.6%),其次是IgA肾病(13%)和局灶节段性肾小球硬化(12.2%)。
这是巴西全国肾脏活检登记处的首份报告。这些数据提供了有关这个幅员辽阔国家肾脏疾病概况的关键信息。